SCHEDULE 13G/A: Alyeska Investment Group Discloses Passive Stake in Guardian Pharmacy Services
Beneficial Ownership Disclosure (Schedule 13G Amendment)
Alyeska Investment Group, L.P., along with Alyeska Fund GP, LLC and Anand Parekh, has disclosed a passive beneficial ownership of 4.66% in Guardian Pharmacy Services, Inc.'s Class A Common Stock as of December 31, 2024.
Summary
- Alyeska Investment Group, L.P., Alyeska Fund GP, LLC, and Anand Parekh collectively reported beneficial ownership of 428,570 shares of Guardian Pharmacy Services, Inc.'s Class A Common Stock.
- This ownership represents 4.66% of the outstanding Class A Common Stock.
- The filing is an Amendment No. 1 to a Schedule 13G, indicating a change or update to a previously reported passive stake.
- The shares are held with shared voting and shared dispositive power among the reporting persons.
- The reporting persons certified that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing the control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual, regulatory disclosure of beneficial ownership, carrying a neutral sentiment. It neither indicates positive nor negative performance or strategic shifts for the issuer.
Future Outlook
This document, a Schedule 13G, does not contain any forward-looking statements or guidance regarding the issuer's future performance or strategic direction.
Industry Context
This filing is a standard disclosure of a passive investment stake by an investment group in a publicly traded company. It does not provide specific insights into broader industry trends within the pharmacy services sector or competitive landscape, beyond indicating an investment firm's interest in the company.
Stakeholder Impact
- Shareholders: Provides transparency regarding significant passive ownership stakes in the company, confirming that a notable investment group holds a position.
Key Dates
| Date | Description |
|---|---|
| 2024-11-12 | Date of Issuer's Prospectus filing with the SEC, used to determine outstanding shares. |
| 2024-12-31 | Date of event which requires filing of this statement (ownership position as of this date). |
| 2025-02-14 | Date of filing of this Schedule 13G Amendment No. 1. |
Keywords
Guardian Pharmacy Services, Alyeska Investment Group, SEC Filing, Schedule 13G, Beneficial Ownership, Class A Common Stock, Investment Adviser, Passive Investment, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.